Holen Sie sich die Stockscreener-App
0.3716
0.56%
0.0046
Schlusskurs vom Vortag:
$0.3762
Offen:
$0.3876
24-Stunden-Volumen:
125.97K
Relative Volume:
0.03
Marktkapitalisierung:
$1.73M
Einnahmen:
$75,000
Nettoeinkommen (Verlust:
$-42.41M
KGV:
-0.00207
EPS:
-179.8206
Netto-Cashflow:
$-18.47M
1W Leistung:
-6.48%
1M Leistung:
-34.44%
6M Leistung:
-96.85%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.3676
$0.3876
1-Wochen-Bereich:
$0.3613
$0.4198
52-Wochen-Spanne:
$0.3613
$166.50
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3716 | 1.75M | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
86.65 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.23 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.82 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.81 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.73 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Profusa (NASDAQ: PFSA) eyes major reverse split, $30M PanOmics stock acquisition and note conversion - Stock Titan
Profusa Amends $30 Million Asset Purchase of PanOmics Assay, Drops 12% Management Equity Grant - TradingView
[8-K] Profusa, Inc. Reports Material Event - Stock Titan
PFSA Should I Buy - Intellectia AI
Profusa, Inc. Submits Advance Notice for Equity Line Share Purchase with Ascent Partners Fund LLC – SEC Filing 8-K May 18, 2026 - Minichart
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa submits equity purchase notice to Ascent Partners under credit agreement - Investing.com Nigeria
Profusa (NASDAQ: PFSA) registers 179.3M resale shares; Ascent equity line terms detailed - Stock Titan
Profusa Taps Equity Line for Near-Term Liquidity - TipRanks
Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism - TradingView
Profusa (NASDAQ: PFSA) details May equity line share purchase terms - Stock Titan
Number of shareholders of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Transfers Nasdaq Listing Amid Ongoing Compliance Uncertainty - The Globe and Mail
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Profusa (NASDAQ: PFSA) Q1 2026 loss deepens amid going concern and Nasdaq listing pressure - Stock Titan
Profusa, Inc. Announces Transfer to Nasdaq Capital Market to Ensure Continued Listing Compliance - Minichart
Profusa to Transfer Listing to The Nasdaq Capital Market Effective May 15, 2026 - TradingView
Profusa (Nasdaq: PFSA) shifts stock listing to Nasdaq Capital Market tier - Stock Titan
Profusa moves to Nasdaq Capital Market amid compliance efforts By Investing.com - Investing.com Australia
Profusa moves to Nasdaq Capital Market amid compliance efforts - Investing.com
Profusa Announces Listing Transfer to The Nasdaq Capital Market - The Manila Times
Profusa announces listing transfer to the Nasdaq Capital Market - marketscreener.com
Digital health company Profusa shifts Nasdaq tier to meet listing rules - Stock Titan
Profusa granted transfer to Nasdaq Capital Market, faces July compliance deadline - MSN
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa (NASDAQ: PFSA) seeks vote on reverse split, $30M Bio Insights deal - Stock Titan
Number of shareholders of PROFUSA, INC. – OTC:NVACW - TradingView
NVACW | PROFUSA INC WTS Insider Trading - Quiver Quantitative
Profusa Granted Conditional Nasdaq Listing Extension and Transfer - TipRanks
Profusa Receives Favorable Nasdaq Listing Determination - The Manila Times
Profusa, Inc. Granted Transfer to Nasdaq Capital Market Amid Compliance Efforts - Quiver Quantitative
Conditional Nasdaq listing relief for Profusa (NASDAQ: PFSA) - Stock Titan
Profusa keeps Nasdaq listing if it meets July 6 price and equity rules - Stock Titan
Profusa Secures New Convertible Note and Warrant Financing - TipRanks
Profusa (PFSA) insider-linked LLC converts $1.87M note into 5.34M shares - Stock Titan
Profusa (PFSA) CFO-linked LLC converts $1,869,796 note into 5.34M shares - Stock Titan
Profusa initiates strategic review, focuses on European approval By Investing.com - Investing.com Australia
Profusa initiates strategic review, focuses on European approval - Investing.com
Profusa Inc Profusa initiates board-led process to evaluate strategic alternatives and maximize shareholder value - marketscreener.com
Profusa Inc Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives And Maximize Shareholder Value - TradingView
Profusa starts deal review after Lumee Oxygen completes two EU audits - Stock Titan
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value - marketscreener.com
[EFFECT] Profusa, Inc. SEC Filing - Stock Titan
Finanzdaten der Profusa Inc-Aktie (PFSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):